Daglutril acetic acid
(Rac) -Daglutril (SLV 306 acetic acid) is the racemic mixture of Daglutril, an orally administered dual inhibitor of neutral endopeptidase and endothelin-converting enzyme. It has been investigated in preclinical and clinical studies for potential therapeutic applications in essential hypertension and congestive heart failure.
Product Specifications
Product Name Alternative
2- ((3S) -3- (1- (2- (ethoxycarbonyl) -4-phenylbutyl) cyclopentane-1-carboxamido) -2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl) acetic acid, Daglutril, Daglutril acetic acid, SLV 306 acetic acid, SLV 306 acetic acid
Field of Research
Pharmacology & Drug Discovery
Purity
98.54% (May vary between batches)
Solubility
DMSO:50 mg/mL (93.52 mM)
Smiles
O=C (O) CN1C2=CC=CC=C2CC[C@H] (NC (C3 (CC (C (OCC) =O) CCC4=CC=CC=C4) CCCC3) =O) C1=O
Molecular Formula
C31H38N2O6
Molecular Weight
534.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
